← Back to Search

Procedure

Treatment for Arrhythmia (PSOT-PMCF Trial)

N/A
Waitlist Available
Led By Anish Amin, MD
Research Sponsored by EPD Solutions, A Philips Company
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Summary

Study to evaluate the safety and procedural performance of the KODEX - EPD System when used in the treatment of cardiac arrhythmias. An additional objective is to develop patient specific optimized therapy (PSOT PMCF) via machine learning to improve future treatment of cardiac arrhythmias (PSOT).

Eligible Conditions
  • Arrhythmia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Acute safety event rate when using the KODEX - EPD System
The success rate of the index ablation procedure.
Secondary study objectives
Vaginal System
Develop PSOT for cardiac arrhythmia patients.

Find a Location

Who is running the clinical trial?

EPD Solutions, A Philips CompanyLead Sponsor
7 Previous Clinical Trials
728 Total Patients Enrolled
2 Trials studying Arrhythmia
30 Patients Enrolled for Arrhythmia
Anish Amin, MDPrincipal InvestigatorOhioHealth Riverside Methodist Hospital
Min Tang, MDPrincipal InvestigatorChinese Academy of Medical Sciences, Fuwai Hospital
~84 spots leftby Sep 2025